What is the Market's View on Hookipa Pharma Inc (HOOK) Stock's Price and Volume Trends Friday?

Overall market sentiment has been down on Hookipa Pharma Inc (HOOK) stock lately. HOOK receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Hookipa Pharma Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on HOOK!

See Full HOOK Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With HOOK Stock Today?

Hookipa Pharma Inc (HOOK) stock is trading at $1.52 as of 10:21 AM on Friday, Apr 22, a decline of -$0.02, or -1.62% from the previous closing price of $1.54. The stock has traded between $1.50 and $1.58 so far today. Volume today is less active than usual. So far 47,643 shares have traded compared to average volume of 1,518,995 shares. To screen for more stocks like Hookipa Pharma Inc click here.

More About Hookipa Pharma Inc

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies. Click Here to get the full Stock Report for Hookipa Pharma Inc stock.